Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares tumbled nearly 7% today, after J.
Array Biopharma Inc (NASDAQ:ARRY) investors celebrated Monday’s positive COLUMBUS Phase 3 results for its BRAF-mutant melanoma cancer treating pipeline drug BRAFI encorafenib, an oral small …
Tuesday turned out to be a nightmare for shareholders of PTC Therapeutics, Inc. (NASDAQ:PTCT) as the stock price tumbled over 55%, after the biotech company received …
J.P.
